Back to Atlas
APotentially durableStandard research/education caution
CMP-0128
Approved/compounded/restricted
Testosterone base / Testosterone suspension
Ergogenic / AAS
Rapid testosterone exposure with anabolic-androgenic effects
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- Unesterified testosterone
- Primary mechanism
- Androgen receptor agonist; A:A ratio 1:1 baseline
- Primary market use
- Androgen replacement / performance misuse
Pharmacology
- Molecular weight (Da)
- 288.42
- Oral bioavailability
- Oral poor; N/A for injectable suspension
- Half-life
- Hours; short apparent duration
- Route tags
- Route-dependent / verify
- Evidence level
- Approved/historical
- Clinical status
- Approved/compounded/restricted
- Value-for-money score
- 7 / 10
Reported protocol signal
No popular protocol verified yet; keep as reference compound until protocol signal is added.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
Unesterified testosterone; rapid kinetics compared with depot esters.